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Abstract
Object The aim of this study was to determine the impact
to PET quantification, image quality and possible diag-
nostic impact of an anterior surface array used in a com-
bined PET/MR imaging system.
Materials and methods An extended oval phantom and
15 whole-body FDG PET/CT subjects were re-imaged for
one bed position following placement of an anterior array
coil at a clinically realistic position. The CT scan, used for
PET attenuation correction, did not include the coil.
Comparison, including liver SUVmean, was performed
between the coil present and absent images using two
methods of PET reconstruction. Due to the time delay
between PET scans, a model was used to account for
average physiologic time change of SUV.
Results On phantom data, neglecting the coil caused a
mean bias of -8.2 % for non-TOF/PSF reconstruction, and
-7.3 % with TOF/PSF. On clinical data, the liver SUV
neglecting the coil presence fell by -6.1 % (±6.5 %) for
non-TOF/PSF reconstruction; respectively -5.2 % (±5.3 %)
with TOF/PSF. All FDG-avid features seen with TOF/PSF
were also seen with non-TOF/PSF reconstruction.
Conclusion Neglecting coil attenuation for this anterior
array coil results in a small but significant reduction in liver
SUVmean but was not found to change the clinical inter-
pretation of the PET images.
Keywords Positron-emission tomography  Magnetic
resonance imaging  Attenuation correction
Introduction
In a dedicated PET/MR imaging system, traditional methods
of accounting for PET attenuation cannot be utilized. Sev-
eral publications [1–3] have explored the use of segmenta-
tion of MR image data to obtain the patient component of
attenuation, but several challenges remain [4–6]. One sig-
nificant challenge is in the area of MR surface coils.
Depending on the coil design, significant artifacts and
quantification errors can occur in the PET images if the coil
is not accounted for in the attenuation map used in image
reconstruction [7–11]. The impact of the coil depends on the
placement of the coil relative to the patient, as well as the
location within the coil of any dense, compact elements.
To characterize an impact, several important PET met-
rics imaging should be considered. The first goal of a PET
study is to detect normal and abnormal radiotracer uptake
throughout the body. Image artifacts can occlude important
diagnostic findings, such as when streak artifacts projecting
back through the image hinder location of a high-uptake
lesion or evaluation of normal anatomy. The second goal in
PET is to localize an area of interest, typically an FDG-
avid tumor in whole-body oncologic PET. For this purpose,
the spatial accuracy and spatial invariance of quantification
accuracy are important. To localize a feature and under-
stand its relationship to nearby structures, visual inspection
of the images, including use of both PET and CT or MR
images, is typically performed. In some cases, margins may
be defined through use of automated segmentation or
manual delineation to define the extent of the tumor. A
third goal of quantitative PET is to determine the actual
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radiotracer uptake of the area-of-interest. This goal often
has multiple elements, including definition of a volume-of-
interest (VOI) in a reference organ (e.g. liver), as well as
the standard uptake value (SUV) of a lesion. Given that
there are multiple diagnostic requirements of the image
data, multiple metrics should be used to determine how
well the above goals are met. Therefore, multiple measures
were considered in this study and used to determine the
impact of an MR anterior array (AA) surface coil within a
PET/MR imaging system.
In performing this study, PET image data at multiple
time points must be compared—in this case, data from a
bed position acquired during a whole-body series of bed
positions without the AA coil to that from a bed position
acquired later with the coil positioned on the patient. Since
PET data is typically decay-corrected to the start of the
scan, the single bed position with the AA coil present
required further decay correction to the start of the whole-
body study. A more difficult and potentially confounding
parameter, however, was accounting for any bio-redistri-
bution that occurs during the time between scans. Uptake
timing is often considered when the standardization of
imaging protocol is of importance [12–14], but it is also
realized that dual time-point PET has potential diagnostic
use because of the bio-redistribution [15, 16], although
there is some discrepancy concerning its clinical relevance.
Since the effects due to the presence of the coil are
hypothesized to be small,\10 % change in SUV, the effect
of bio-redistribution was included as a contributor to dif-
ferences between scans since tissue volume SUVs were
compared at multiple time points. However, all of these
effects might be just of technical or hypothetical nature and
therefore the actual diagnostic impact on a clinical routine
readout of those studies must also be considered.
The aim of this study was to determine the impact of an
anterior array surface coil if an attenuation map for the coil
is neglected within PET image reconstruction in a dedi-
cated PET/MR imaging system. The impact was measured
by considering PET images and image difference maps
(with/without AA coil), SUV quantification in the liver and
per-pixel SUV joint histogram analysis. The impact with
use of time-of-flight (TOF) PET as compared to non-TOF
PET was also evaluated under the hypothesis that use of the
TOF information helps localize the impact of the attenua-
tion data inconsistency when neglecting the coil attenua-
tion [17]. Lastly, a clinical routine read-out of the scans
with and without the coil was performed and the readers
determined the clinical impact.
Materials and methods
Phantom study
A phantom study was conducted using the AA coil on the
top of an extended oval phantom (25.3 L) using the
arrangement shown in Fig. 1a. The phantom (Data Spec-
trumTM, Hillsborough NC) was filled with a uniform dis-
tribution of 18F-FDG. Using a Discovery 690 PET/CT
system (GE Healthcare, Waukesha WI) PET scans were
subsequently acquired without and with the AA coil. A CT
scan was acquired with no coil present, for the purpose of
attenuation correction for both coil-present and coil-absent
scans. The total activity was 159.0 MBq (6.3 kBq/mL) at
the beginning of the scan without coil, and 105.5 MBq
(4.2 kBq/mL) at the beginning of the scan with coil. The
acquisition times were set such that both scans acquired an
equivalent number of annihilations (60 and 102 min,
respectively).
PET image reconstruction of the phantom, with both
non-TOF and TOF, used a 192 9 192 grid over 400 mm
transaxial FOV and two iterations, and 24 subsets of
OS-EM followed by a 4.0 mm Gaussian post-filter. Images
were compared at three axial locations and a PET SUV
image joint histogram analysis was performed for voxels in
the range of 0.1–2.5 SUV (g/ml). The SUV value of the
Fig. 1 The GE GEM anterior array coil measures 55.6x67.4x3.3 cm,
weighs 2.8 kg and is mainly made of foam, with Lexan plastic for
feed and decoupling board housing. The cable is connected to the
upper right board, weights 1.1 kg and has a diameter of 11 mm,
including insulation. a Photograph of the anterior array coil placed
onto a uniformly filled oval phantom. b Render of an oblique view CT
image of the coil placed onto an extended oval phantom. c Same view
at a different render level
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difference (coil present, coil absent) images was also cal-
culated and the average SUV values from two representa-
tive regions in the difference images were found.
Clinical data acquisition
Fifteen patient studies were acquired with whole-body FDG
PET/CT imaging. The imaging protocol included
14–18 min for whole-body PET/CT acquired depending on
the size of the patient. The average patient weight was
72 ± 12 kg, the average BMI was 26 ± 5 kg/m2 and the
average FDG dose was 310 ± 13 MBq. The present study
did not involve any extra radiation dose delivered to the
patients. First, a helical CT scan covering the PET imaging
field-of-view (FOV) was acquired and subsequently used for
attenuation correction of all PET data, including when the
AA coil was present. Next, 6–8 bed positions were acquired
for whole-body FDG PET imaging. After the whole-body
scan completed, the patient was transported out of the
imaging bore and the AA coil was placed by the technolo-
gists at a ‘typical use’ location. Thus, each patient had a
somewhat different location of the AA coil. Notice that,
given the coil dimensions, the liver was covered in all cases.
Finally, out of all the bed positions defined and acquired
during the routine PET/CT scan, the one currently covered
by the coil was re-acquired such that the patient was at the
same nominal location as during the whole-body scan. This
bed position always had partial coverage of the liver,
enabling the impact on liver tissue uptake to be measured
and compared. The average time between the bed position
imaged with AA coil and the ‘no-coil’ bed position (within
the whole-body scan) was 14.0 ± 2.9 min. PET image
comparisons were performed in SUV units, hence the decay
time between scans was not a factor in the analysis.
PET images were formed using a fully-3D OS-EM
iterative reconstruction (VuePoint HD) with two iterations,
and 24 subsets onto a 256 9 256 image grid (2.73 9
2.73 9 3.27 mm voxels) over a 700 mm diameter FOV.
Images were filtered in image space using a 4.0 mm
FWHM in-plane Gaussian filter followed by an axial filter
with a 3-slice kernel using relative weights of 1:4:1. All
quantitative corrections, including normalization, dead-
time, randoms, scatter and attenuation, were applied during
image reconstruction. The TOF image reconstructions
(VuePoint-FXS) used the same reconstruction parameters
except with three iterations and 18 subsets and included
point-spread-function (PSF) compensation. It is worth
pointing out that the single-bed reconstructions with the
AA coil placed on top of the patient’s body are expected to
have increased but unbiased noise near the axial end slices.
This investigation was performed in collaboration
between GE Healthcare and the Department of Medical
Imaging, University Hospital, Zurich, Switzerland.
Clinical data analysis
For each patient, the location of a liver VOI of size
7 9 7 9 7 voxels, or approximately 8.4 ml, was deter-
mined from the reconstructed PET images. Voxels within
the VOI were averaged to find the SUVmean in g/ml in order
to compare the data with the AA coil present to that from
the standard clinical data without the coil. A percent dif-
ference between the liver SUVmean with and without the
coil was plotted along with the mean and ±1 standard
deviation across studies. Paired t tests were performed to
determine significance of with- versus without-coil results.
In order to compare liver SUV at two time points, the
physiologic change in FDG distribution in liver was taken
into account using the data from Laffon et al. [18]. Their
work presented data from 11 patients where two mea-
surements of SUVmean in a liver VOI were found at two
times post-FDG injection. For each of these 11 patients, the
rate-of-change slope (DSUV/Dtime) was calculated [first
time point 72.2 ± 11.6 min (55.0, 89.0), second time point
at 158.6 ± 19.6 min (130.0, 194.0), average time between
points 86.5 ± 16.6 min (63.0, 115.0)]. Assuming that
change between the time points was linear and that the data
were representative of the same population used in our
study, the amount of expected SUV change could be
accounted for between the coil-absent data and the coil-
present data in order to account for expected normal bio-
redistribution change.
Besides the localized error measures provided by VOI
analysis, joint image histograms of voxel-wise PET SUV
were generated, in order to compare the overall results with
Fig. 2 Plot for all 15 patients of liver SUVmean showing the early
time point (coil-absent) and later time point (coil-present). The red
lines indicate expected normal liver FDG SUV change over the same
time period
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and without the coil. Voxels from both images that were
between 0.1 and 5.0 g/ml were included in the plots. A
regression line was determined from the data with intercept
forced through the origin. The slope of the line and the
adjusted R2 were found for each patient comparison with
and without the AA coil.
All comparisons were done between coil-present and
coil-absent images using the TOF images as well as using
the non-TOF images.
Diagnostic evaluation
To determine the influence of the coil on the PET data,
several parameters were assessed qualitatively in the same
manner as was used in typical clinical routine. One dual
board-certified radiologist/nuclear medicine physician and
a board-certified radiologist with substantial nuclear med-
icine experience evaluated the images. The following four
sets of images were evaluated: (a) TOF without coil (ref-
erence study), (b) TOF with coil, (c) non-TOF without coil,
and (d) non-TOF with coil. It was determined by the
clinical readers (1) whether any lesion was detected within
the FOV, (2) whether lesions were perceived as qualita-
tively equal in all studies, using as a reference the TOF
PET-CT without coil, (3) whether the clinical report would
have been changed based on the coil-present images and
(4) whether reader confidence changed concerning the
characterization of any lesion. Qualitative parameters for
evaluation (2) included rating the sharpness of lesions
using a 4-point scale: 1 = sharp, 2 = blurring noted on
some edge pixels, 3 = blurring noted on most edge pixels,
4 = entire lesion blurred. The conspicuity of a lesion’s
border, as well as its localization with respect to the ref-
erence study, were also determined.
Results
Phantom study
A set of images with and without the AA coil on the
extended oval phantom using non-TOF PET reconstruction
(VuePoint HD) and TOF reconstruction (VuePoint FX) are
shown in Fig. 3. The joint histogram results comparing the
PET phantom images with and without the AA coil are
shown in Fig. 4. The results of VOI analysis are shown in
Fig. 5. Two representative areas were measured and found
to have biases of -2.3 and -14.2 % for non-TOF/PSF
reconstruction. With TOF/PSF, the biases were, respec-
tively, -5.4 and -9.2 %. The mean reconstructed SUV was
measured to be 1.13 g/mL without TOF and 1.07 g/mL with
TOF. These deviations from the ideal 1.00 g/mL are within
the expected range for this kind of measurement, and can be
explained by the accuracy of the dose calibrator measure-
ment, the phantom volume measurement and the system
corrections (e.g. the scatter model).
Clinical study
The average time from injection to scan start was 80.6 min
[±10.7 min, range (61.5, 94.8)]. The average delay time
between coil-absent and coil present scans was 14.0 min
[± 2.9 min, range (11.9, 23.4)]. From the data in [18],
the slope for rate of change in liver SUVmean was
-5.5 ± 1.3 9 10-3 (g/ml/min) and was very consistent
over the 11 patients included in that study. This rate of
change was applied to each of the 15 studies based upon its
time difference between coil-absent and coil-present
scanning and subtracted from the observed difference.
Over the 15 studies, this accounted for, on average, a 3.5 %
portion of the difference observed in liver SUVmean.
A plot of the decay-corrected liver SUVs for the 15
patients comparing coil-absent with coil-present images is
shown in Fig. 2. These data represent the PET image
measurements using TOF reconstruction. Note how, in
three cases, data were acquired before the liver activity
peak estimated by Laffon et al. This could, potentially,
cause a minor masking of the impact of hardware attenu-
ation on the second measurement.
A chart showing the comparison between coil-absent and
coil-present liver VOI SUVmean for both TOF and non-TOF
data is shown in Fig. 6. The numeric results are contained in
Table 1. The plot in Fig. 7 shows the percent differences
between coil-absent and coil-present liver VOI SUVmean for
both TOF and non-TOF image reconstructions.
PET axial, sagittal and coronal images, without and with
the AA coil, from a representative patient are shown in
Fig. 8. These images utilize the TOF and PSF within image
reconstruction. Figure 9 shows the non-TOF, no PSF axial
images without and with AA coil for this same patient.
Results from the other patients were similar to those shown
in this example.
Joint histograms for these two patient studies are shown
in Fig. 10 using a logarithmic color scale for frequency.
Notice that these histograms do not account for the bio-
distribution of the radiotracer in the liver over time. Joint
histograms for other datasets were similar except for P015,
which had a joint histogram fit slope of 0.995 for both non-
TOF and with TOF/PSF comparisons. The joint histogram
fit results for all patients and both reconstruction methods
are shown in Table 2.
Change in liver SUV comparing presence and absence of
the AA coil was evaluated using a paired t-test for the PET
images with TOF and PSF: the mean difference between
coil-present and coil-absent was significant (M = 0.112
g/ml, SD = 0.110, N = 15), with t(15) = 3.94, two-tail
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p = 0.001 and a 95 % C.I. about the mean difference of
[0.05, 0.17]. With the non-TOF/PSF PET images, the mean
difference was also significant (M = 0.142 g/ml, SD =
0.137, N = 15), with t(15) = 4.01, two-tail p = 0.001 and
a 95 % C.I. about the mean difference of [0.07, 0.22]. Both
PET image reconstruction methods showed a significant,
measureable difference in liver SUV in the VOI, albeit this
was only a 5 % difference on average across the patients.
The range of the liver SUV differences between images
with and without the AA coil using TOF/PSF was [-11.5,
7.8 %] and using non-TOF/PSF PET images was [-5.6,
11.2 %], after accounting for the average FDG liver uptake
change over time.
To understand the utility of the PET TOF information,
the significance of the slope of the joint histogram linear fit
comparing presence and absence of the AA coil was
evaluated using a paired t test for the two PET image
reconstruction methods. The mean of the slope difference
was significant (M = 0.012, SD = 0.006, N = 15), with
t(15) = 7.58, two-tail p = 2.54e-06, and a 95 % C.I. about
the mean slope difference of [0.008, 0.015]. These results
provide evidence that using the TOF information produced
a more accurate overall PET SUV image in the presence of
the un-accounted coil attenuation.
The clinical diagnostic evaluation revealed 13 patho-
logical lesions in seven of the 15 patients. All lesions
were detected in all four types of PET images (with and
without coil, with and without TOF/PSF). However, slight
qualitative differences were noted. In three patients, the
lesion and the normal anatomical structures were noted to
Fig. 3 PET/CT images without and with the AA coil present, for a central axial slice location, using non-TOF (left) and TOF PET
reconstruction. In all cases, the attenuation correction did not include the coil. PET coil/no coil difference images are shown in the bottom row
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be less sharp (ranked 3 on the aforementioned four-point
scale) in the coil-present image. In all other patients and
lesions, no qualitative difference was noted. The opposite
occurred in one patient, where a slight overlap artifact
within the liver between the bed positions was absent on
the coil-present (single-bed-position) images. Overall, and
most importantly, the readers would not have changed
their report concerning the diagnostic results or concern-
ing the characterization of the lesions. Furthermore, no
difference in reader confidence was noted between the
TOF-with-coil images and TOF-without-coil images.
However, as expected, all non-TOF (non-PSF) images
Fig. 4 Joint histogram of PET
images comparing with AA coil
to without AA coil for non-TOF
(left) and with TOF (right). PET
image voxels between 0.1 and
2.5 g/ml were included in the
analysis. A linear fit through the
origin is shown. Statistical
results of the difference images
for the two reconstruction
methods are shown below the
histograms
Fig. 5 PET axial, coronal and
sagittal difference images of the
oval phantom (with—without
coil) for non-TOF and TOF PET
images. ROI analysis results are
also shown for the two regions
marked as red boxes in the
images. The mean SUV was
1.13 g/mL for non-TOF
reconstruction and 1.07 g/mL
with TOF
Fig. 6 Bar chart of all liver
VOI SUVmean values comparing
coil-absent (PET) to coil-
present (PET_AA) for both TOF
and non-TOF reconstructions
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were rated as more blurry/less sharp than the TOF/PSF
images with a typical lesion rank of 3.
Discussion
Given the design of the AA coil used in this study, the
initial hypothesis was that the net effect would be less
than 10 % on the quantitation for PET. In contrast,
Martinez-Mo¨ller et al. [1] reported average SUV changes
up to 13 %, using their 4-class MR-based attenuation
correction approach, whereas Keereman et al. [3] claim
errors up to 5 % using a 5-class approach.
The results demonstrate that the coil, while having a
measureable impact on PET quantitation, has little impact
on clinical image quality for both PET reconstruction
approaches. This is confirmed by the results of the phantom
study, which show that the bias introduced by the coil
Table 1 Results for liver
SUVmean for the 15 subjects,
including the coil present/absent
comparison within PET
reconstruction methods
Physiologic SUV change (3.5 %
on average) has been
individually accounted for
Liver SUVmean/ N = 15 PET/CT: non-TOF
(-physio)
PETAA/CT:
non-TOF
PET/CT: TOF/PSF
(-physio)
PETAA/CT:
TOF/PSF
Avg 2.20 2.06 2.15 2.04
Std 0.36 0.32 0.34 0.36
Max 2.88 2.75 2.91 2.99
Min 1.56 1.62 1.60 1.55
Avg. % diff., account for physio
D
Avg -6.1 % -5.2 %
Std 6.5 % 5.3 %
Max 10.7 % 7.8 %
Min -13.7 % -11.5 %
Fig. 7 Plot of the coil-absent/
coil-present percent differences
per patient of the liver VOI
SUVmean for each image
reconstruction method (TOF,
non-TOF)
(a) (b) (c)
+2.5 
g/mL
-2.5
+5 
g/mL
0
+5 
g/mL
0
+225 
g/mL
-350
Fig. 8 Patient P011 axial (a),
sagittal (b) and coronal
(c) images of, from top to
bottom: CT scan; TOF PET
without AA coil; TOF PET with
coil; and PET SUV absolute
difference images (PET/CT—
PET_AA/CT). SUV images are
shown with window [0, 5] g/ml
and difference images are with a
[-2.5, 2.5] g/ml window
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presence (as high as -14.1 % when no TOF information is
used) has a low-frequency pattern that is less susceptible to
lead to clinically relevant errors.
In order to measure a small impact in quantitation for a
dual-time-point FDG-PET study, a first order approxima-
tion of the model in [18] was used, assuming the behavior
they observed applied to the subjects included in this study
(note how Laffon’s measurements are approximately
90 min apart, in contrast to approximately 15 min in the
present study). While this is not proven as part of this
study, it was considered reasonable to include such a term
describing the FDG wash-out as well as to use the model
(a) (b)
+5 
g/mL
0
+5 
g/mL
0
Fig. 9 Non-TOF/PSF axial PET images for two patient cases: P004
(top row) and P011 without a and with b AA coil
Fig. 10 Joint histograms with a logarithmic frequency scale for P004 a and P011 b with non-TOF/PSF (top row) and with TOF/PSF (bottom
row). Note how these do not account for the effect of tracer redistribution
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described since the data could not practically be acquired
as quickly as necessary to ignore such a model or correc-
tion term.
When including the TOF information, the impact of
neglecting the coil attenuation is reduced, but only by a
small fraction of the overall impact. This result is consis-
tent with current PET/CT TOF resolution for this system,
which is on the order of 550 ps [19] and has the main
impact of reducing noise for larger patients. This
improvement with TOF can also be seen in the percent
difference comparison shown in Fig. 7.
Inspection of the joint histogram results in Table 2,
which account for changes throughout the full PET image
volume, shows that both reconstruction methods perform
well in maintaining the full-volume PET quantitation.
Including TOF information moves the slope of the fit line
slightly toward the identity line, but only by a small
amount. This type of image data analysis has utility in that
the performance over the whole image can be condensed
into a single metric, in order to compare two approaches
and determine which produces a result closer to the base-
line approach.
Visual inspection of the PET images and image differ-
ences across all subjects demonstrated that the image
changes were mostly distributed throughout the image
volume and were not apparent due to focal artifacts. This is
important since one of the primary imaging goals is lesion
detection, and loss of detection capability due to streaks or
other inaccurate correction artifacts prioritizes the need to
change coil design or incorporate methods to correct for the
coil attenuation in a combined PET/MR system. Given that
this coil is both flexible and designed to be placed
according to patient anatomy over a wide range of patient
sizes, approaches for coil localization are complex and
likely prone to localization errors [9, 11] which may be on
the order of the error induced by simply neglecting the coil
attenuation. The comparison results that appear to be out-
liers, evident in Fig. 7 for P007, P009, P010 and P015, are
potentially due to either liver FDG clearance that does not
follow that demonstrated in Laffon et al., i.e. reconstruction
noise near the edges of the field of view, or patient motion.
Inspection of the images for these cases as part of the
clinical evaluation did not implicate any cause related to
presence of the AA coil, and both the coil-present and coil-
absent PET image data were similar to other cases.
For the clinical comparison, there is currently no data
available in the literature comparing the diagnostic impact
of having a coil within the FOV of the PET as compared to
the coil-absent images (with the exception of a single
patient measurement reported in [11], where the coil
caused a bias of -11.4 % on a pancreas carcinoma). Early
PET/MRI evaluations did not report any significant image
artifacts noted from the coil [20–22]. However, these
studies did not compare with non-coil images. Addition-
ally, the physiologic decay was not taken into account in
any of the available studies. Thus, the results presented
here represent to our opinion the most relevant evaluation
of the diagnostic impact of a coil within the FOV when its
attenuation is not accounted for.
Similar phenomena concerning the diagnostic relevance
have been recently reported when comparing CT-AC and
MR-AC imaging [23]. For consistency in the lesion to
background ratio, our study included only FDG whereas
tracers beyond FDG were included in the evaluation in
[23]. Even though significant differences were found in the
quantitation of liver uptake, no significant clinical impact
was demonstrated. Further efforts are currently being
undertaken to determine and correct coil attenuation that
include more sophisticated sequences that can also be used
for MR-AC, such as ultra-short TE [24]. The results pre-
sented here represent a lower limit on the accuracy required
when accounting for the coil attenuation.
The results presented in this study are limited to the GE
GEM anterior array coil, but are likely to be similar for
other flat, flexible coils of similar size and composition.
New coil designs with lighter casing materials and opti-
mized arrangement of the more massive electronic com-
ponents may further reduce the errors introduced by the
coil. The procedures described here can be easily applied to
evaluate other coils and coil configurations (e.g. the
Table 2 Linear fit slope and adjusted R2 for voxels with joint SUV
between [0.1, 5.0], all patients and both reconstruction methods
Non-TOF/PSF TOF/PSF Slope
(TOF-nonTOF)
Slope R2 Slope R2
p001 0.888 0.680 0.906 0.640 0.018
p002 0.854 0.830 0.870 0.850 0.016
p003 0.905 0.860 0.918 0.870 0.013
p004 0.857 0.870 0.874 0.890 0.017
p005 0.853 0.870 0.861 0.870 0.008
p006 0.838 0.800 0.855 0.830 0.017
p007 0.891 0.880 0.893 0.900 0.002
p008 0.885 0.820 0.902 0.850 0.017
p009 0.855 0.840 0.866 0.870 0.011
p010 0.898 0.870 0.906 0.890 0.008
p011 0.876 0.910 0.889 0.930 0.013
p012 0.859 0.880 0.871 0.890 0.012
p013 0.870 0.870 0.875 0.890 0.005
p014 0.893 0.600 0.912 0.560 0.019
p015 0.995 0.790 0.995 0.810 0.000
avg 0.881 0.825 0.893 0.836 0.012
std 0.037 0.083 0.035 0.101 0.006
min 0.838 0.600 0.855 0.560 0.000
max 0.995 0.910 0.995 0.930 0.019
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peripheral-vascular array). One factor that will need further
study is the impact of the coil cable attenuation, in those
cases where the cable cannot be placed away from the
structures of interest.
A considerable limitation of our study is certainly the
small number of patients. However, it represents a first
study to compare coil-present to coil-absent imaging in
patients using a standard clinical coil and it demonstrates
results in both a technical and in a clinical diagnostic way.
Further, the results account for tracer redistribution, which
is necessary in dual-time-point studies when looking for
small SUV differences not caused by physiologic change
over time.
Conclusion
The results demonstrate that use of the MR anterior array
coil did produce statistically significant but generally small
changes in liver SUV, approximately on the order of 5 %.
No clinically significant differences were demonstrated
when the coil was used within the PET-FOV. Further, only
a slight decrease in lesion conspicuity during the clinical
analysis of pathologic lesions was noted in the images with
the coil present for three of 15 patients, which could
potentially be due to increased image noise from the later
imaging time for the coil-present images. Further efforts
are underway to validate the robustness of these compar-
ative analysis methods on a larger patient population, as
well as to identify coil design improvements that will lead
to increased PET quantification accuracy.
Acknowledgments The authors would like to thank Prof. G. K. von
Schulthess and collaborators at the University Hospital of Zurich for
collection of and access to the patient data used in this study.
References
1. Martinez-Moller A, Souvatzoglou M, Delso G, Bundschuh RA,
Chefd’hotel C, Ziegler SI, Navab N, Schwaiger M, Nekolla SG
(2009) Tissue classification as a potential approach for attenua-
tion correction in whole-body PET/MRI: evaluation with PET/CT
data. J Nucl Med 50(4):520–526
2. Hofmann M, Pichler B, Scholkopf B, Beyer T (2009) Towards
quantitative PET/MRI: a review of MR-based attenuation cor-
rection techniques. Eur J Nucl Med Mol Imaging 36(Suppl 1):
S93–104
3. Keereman V, Holen RV, Mollet P, Vandenberghe S (2011) The
effect of errors in segmented attenuation maps on PET quantifi-
cation. Med Phys 38(11):6010–6019
4. Keereman V, Mollet P, Berker Y, Schulz V, Vandenberghe S
(2012) Challenges and current methods for attenuation correction
in PET/MR. Magn Reson Mater Phy 26(1):81–98
5. Schramm G, Langner J, Hofheinz F, Petr J, Beuthien-Baumann
B, Platzek I, Steinbach J, Kotzerke J, van den Hoff J (2012)
Quantitative accuracy of attenuation correction in the Philips
Ingenuity TF whole-body PET/MR system: a direct comparison
with transmission-based attenuation correction. Magn Reson
Mater Phy 26(1):115–126
6. Keller SH, Holm S, Hansen AE, Sattler B, Andersen F, Klausen
TL, Hojgaard L, Kjaer A, Beyer T (2013) Image artifacts from
MR-based attenuation correction in clinical, whole-body PET/
MRI. Magn Reson Mater Phy 26(1):173–181
7. MacDonald LR, Kohlmyer S, Liu C, Lewellen TK, Kinahan PE
(2011) Effects of MR surface coils on PET quantification. Med
Phys 38(6):2948–2956
8. Bin Z, Pal D, Zhiqiang H, Ojha N, Guo T, Muswick G, Chi-hua
T, Kaste J (2009) Attenuation correction for MR table and coils
for a sequential PET/MR system. In: Proceedings of IEEE
Nuclear Science Symposium (NSS/MIC), pp 3303–3306
9. Tellmann L, Quick HH, Bockisch A, Herzog H, Beyer T (2011)
The effect of MR surface coils on PET quantification in whole-
body PET/MR: results from a pseudo-PET/MR phantom study.
Med Phys 38(5):2795–2805
10. Delso G, Martinez-Moller A, Bundschuh RA, Ladebeck R,
Candidus Y, Faul D, Ziegler SI (2010) Evaluation of the atten-
uation properties of MR equipment for its use in a whole-body
PET/MR scanner. Phys Med Biol 55(15):4361–4374
11. Paulus DH, Braun H, Aklan B, Quick HH (2012) Simultaneous
PET/MR imaging: MR-based attenuation correction of local
radiofrequency surface coils. Med Phys 39(7):4306–4315
12. Thie JA, Hubner KF, Smith GT (2002) Optimizing imaging time
for improved performance in oncology PET studies. Mol Imaging
Biol 4(3):238–244
13. Boellaard R, O’Doherty MJ, Weber WA, Mottaghy FM, Lons-
dale MN, Stroobants SG, Oyen WJ, Kotzerke J, Hoekstra OS,
Pruim J, Marsden PK, Tatsch K, Hoekstra CJ, Visser EP, Arends
B, Verzijlbergen FJ, Zijlstra JM, Comans EF, Lammertsma AA,
Paans AM, Willemsen AT, Beyer T, Bockisch A, Schaefer-Pro-
kop C, Delbeke D, Baum RP, Chiti A, Krause BJ (2010) FDG
PET and PET/CT: EANM procedure guidelines for tumour PET
imaging: version 1.0. Eur J Nucl Med Mol Imaging 37(1):
181–200
14. Binns DS, Pirzkall A, Yu W, Callahan J, Mileshkin L, Conti P,
Scott AM, Macfarlane D, Fine BM, Hicks RJ (2011) Compliance
with PET acquisition protocols for therapeutic monitoring of
erlotinib therapy in an international trial for patients with non-
small cell lung cancer. Eur J Nucl Med Mol Imaging 38(4):
642–650
15. Choi WH, Yoo IR, O JH, Kim SH, Chung SK (2011) The value
of dual-time-point 18F-FDG PET/CT for identifying axillary
lymph node metastasis in breast cancer patients. Br J Radiol
84(1003):593–599
16. Zytoon AA, Murakami K, El-Kholy MR, El-Shorbagy E (2008)
Dual time point FDG-PET/CT imaging… Potential tool for
diagnosis of breast cancer. Clin Radiol 63(11):1213–1227
17. Conti M (2011) Why is TOF PET reconstruction a more robust
method in the presence of inconsistent data? Phys Med Biol
56(1):155–168
18. Laffon E, Adhoute X, de Clermont H, Marthan R (2011) Is liver
SUV stable over time in (1)(8)F-FDG PET imaging? J Nucl Med
Technol 39(4):258–263
19. Bettinardi V, Presotto L, Rapisarda E, Picchio M, Gianolli L,
Gilardi MC (2011) Physical performance of the new hybrid
PETCT Discovery-690. Med Phys 38(10):5394–5411
20. Drzezga A, Souvatzoglou M, Eiber M, Beer AJ, Furst S, Marti-
nez-Moller A, Nekolla SG, Ziegler S, Ganter C, Rummeny EJ,
Schwaiger M (2012) First clinical experience with integrated
whole-body PET/MR: comparison to PET/CT in patients with
oncologic diagnoses. J Nucl Med 53(6):845–855
21. Schwenzer NF, Schraml C, Muller M, Brendle C, Sauter A,
Spengler W, Pfannenberg AC, Claussen CD, Schmidt H (2012)
158 Magn Reson Mater Phy (2014) 27:149–159
123
Pulmonary lesion assessment: comparison of whole-body hybrid
MR/PET and PET/CT imaging–pilot study. Radiology 264(2):
551–558
22. Eiber M, Martinez-Moller A, Souvatzoglou M, Holzapfel K,
Pickhard A, Loffelbein D, Santi I, Rummeny EJ, Ziegler S,
Schwaiger M, Nekolla SG, Beer AJ (2011) Value of a Dixon-
based MR/PET attenuation correction sequence for the localiza-
tion and evaluation of PET-positive lesions. Eur J Nucl Med Mol
Imaging 38(9):1691–1701
23. Wiesmuller M, Quick HH, Navalpakkam B, Lell MM, Uder M,
Ritt P, Schmidt D, Beck M, Kuwert T, von Gall CC (2013)
Comparison of lesion detection and quantitation of tracer uptake
between PET from a simultaneously acquiring whole-body PET/
MR hybrid scanner and PET from PET/CT. Eur J Nucl Med Mol
Imaging 40(1):12–21
24. Catana C, Van der Kouwe A, Benner T, Hamm C, Michel CJ,
Fenchel M, Byars L, Schmand M, Sorensen AG (2010) MR-
Based PET attenuation correction for neurological studies using
dual-echo UTE sequences. Proceedings of Joint Annual Meeting
of the International Society of Magnetic Resonance in Medicine
and the European Society for Magnetic Resonance in Medicine
and Biology, Stockholm, p 3953
Magn Reson Mater Phy (2014) 27:149–159 159
123
